Key result
Detection of high biopsychosocial vulnerability using COMPRI and INTERMED identified patients with higher rates of extended hospital stay and poor discharge health status (37% vs 7%).
Why the study?
Do the COMPRI and INTERMED instruments predict extended length of hospital stay and poor discharge health status in medical inpatients?
Observational (n=275)
Do the COMPRI and INTERMED instruments predict extended length of hospital stay and poor discharge health status in medical inpatients?
The COMPRI and INTERMED instruments can effectively identify complex medical inpatients at risk for extended hospital stays and poor health status at discharge.
Answers are grounded in this paper and cite their sources.
May support biopsychosocial screening in medical inpatients; hypothesis-generating and requires prospective trials before practice change.
OBJECTIVE: To detect the patients in medical wards at risk of extended LOS and poor discharge health status with the use of complexity prediction instrument (COMPRI) and interdisciplinary medicine (INTERMED) instruments. METHODS: STUDY 1: In a sample of 275 consecutively admitted medical inpatients, a hierarchical cluster analysis on INTERMED variables was performed. The clusters were compared on length of hospital stay (LOS) and Short Form 36 (SF-36) at discharge. STUDY 2: Receiver operating characteristic (ROC) analysis was used to optimal cut-off points for the COMPRI and INTERMED. Patients detected with COMPRI and INTERMED were then compared with undetected patients on LOS and SF-36. RESULTS: STUDY 1: In concordance with previous findings, a cluster of patients with high biopsychosocial vulnerability was identified with significantly higher scores on LOS (p <.05) and lower scores on SF-36 (p <.001) than patients in other clusters. STUDY 2: A cut-off point for the COMPRI of 5/6 was found to detect patients at risk of long LOS. A cut off score for the INTERMED of 20/21 was found to detect patients at risk of poor discharge health status. Patients detected with COMPRI and INTERMED had a significantly longer LOS (p <.001) and a poorer discharge health status (SF-36 MCS: p <.001; SF-36 PCS: p =.05) than nondetected patients. Of the detected patients, 37% had an extended hospital stay and poor discharge health status; of the nondetected patients, this was only 7%. CONCLUSIONS: The COMPRI-INTERMED can help to detect complex patients admitted to medical wards within the first days of admission, and rule out those with a small chance of poor outcomes.
No takes yet. Share an insight, caveat, or question.
Jonge et al. (2003) conducted an observational in Medical inpatients (n=275). Detection of high biopsychosocial vulnerability using COMPRI and INTERMED vs. Nondetected patients was evaluated on Extended hospital stay and poor discharge health status (p=<.001). Detection of high biopsychosocial vulnerability using COMPRI and INTERMED identified patients with higher rates of extended hospital stay and poor discharge health status (37% vs 7%).
Synapse has enriched 10 related papers. Consider them for comparative context: